Woman, reading or tablet in science laboratory in medical research or innovation ideas of genetic gmo engineering. Plant scientist, worker or biologist on technology in growth sustainability thinking
Pharma  | 9 May 2025

Pharma: Customer Relationship Management in Transition

What the End of the Veeva-Salesforce Partnership Means

Autorenbild Oliver Mende
Oliver Mende

The pharmaceutical industry is under massive pressure to innovate – regulatory demands, rising patient expectations, and rapid technological progress are fundamentally changing the sector. To stay competitive, companies must act faster, be more connected, and operate in a data-driven way. Digital Customer Relationship Management (CRM) is no longer just about sales – it has become the key to personalized communication with Health Care Professionals (HCPs), omnichannel engagement, and efficient clinical processes.


Especially now, as AI, automation, and real-time data processing set new standards, outdated systems and slow decision-making can become serious risks. That’s why it’s more important than ever for pharma companies to prepare in time for major technological shifts – like the launch of the new Salesforce Life Sciences Cloud (LSC), which also marks the end of the partnership between Veeva Systems and Salesforce starting in 2025.


What exactly does the end of the Veeva-Salesforce era mean for users of these tools? What alternatives are available? And why is now the ideal time to review your CRM strategy?

What the End of the Veeva-Salesforce Era Means for Users

The long-standing partnership between Veeva Systems and Salesforce is coming to an end: Starting in September 2025, Veeva CRM will no longer run on the Salesforce platform but will operate exclusively in the Veeva Vault Cloud.

From September 2025, Veeva CRM will enter what's known as Stability Mode on Salesforce. This means:

  • No new features, only bug fixes and security updates

  • Support will be available until September 2030 – but without further development

  • The risk of technological stagnation will rise significantly


For many pharmaceutical companies, this is a clear signal to reassess their current CRM strategy. If you’re one of the users affected, now is the time to ask yourself: Which solution aligns with your future goals? For all companies currently using Veeva CRM, there are now two realistic options:

  1. Switching to the new Veeva Vault CRM platform

  2. Migrating to the Salesforce Life Sciences Cloud


Veeva and Salesforce LSC in Direct Comparison

Our recommendation: Now is the best time to check whether your CRM roadmap is ready for the future. Those who don’t start planning early may face tight resources. To support your decision, we’ve outlined a direct comparison of both systems:


Salesforce Life Sciences Cloud

The new Salesforce Life Sciences Cloud (LSC) offers a modern platform with several benefits:

  • Commercial Operations: Automated field processes, contract management, AI-powered analytics

  • Clinical Operations: Support for traditional and decentralized trials with continuous data flow

  • Pharma CRM: 360° HCP profiles, personalized engagement, and integrated Einstein AI


Bonus: All modules integrate seamlessly with other Salesforce Clouds – for a true end-to-end customer journey.


Veeva Vault CRM

Vault CRM by Veeva has been officially available since April 2024. Initial client implementations began in early 2025. Key advantages of Veeva include:

  • Compliance Standards: Regulatory requirements for Life Sciences are already built-in

  • Familiar Processes: The user journey remains unchanged for current Veeva users


However, the switch also brings challenges:

  • Technical Effort: A full platform migration is needed

  • Rebuilding and Migrating Existing Integrations: Custom code, integrations, and data models must be set up from scratch

Comparison Salesforce Veeva Table

Plan Early, Avoid Risks: Your Personalized Migration Plan

As the end of the Veeva-Salesforce collaboration approaches, companies that have relied on this partnership are under increasing pressure to act. The most important step: early planning. This helps avoid resource bottlenecks, minimize risks – and turn the transition into an opportunity for digital transformation.


As a Salesforce Summit Partner with deep pharma expertise, diva-e offers a comprehensive CRM audit – especially for companies looking to switch from Veeva to Salesforce. The audit includes:

  • Analysis of your current CRM landscape

  • Fit-gap workshop for the new platform

  • Migration plan with effort estimation, risk assessment, and change management strategy


Contact us – we’ll create a tailored strategy for your business to ensure a smooth migration with minimal risk and maximum value.

Autorenbild Oliver Mende

Oliver Mende

Oliver brings over 20 years of experience in life sciences, technology, and digital transformation. Since 2025, he has been working at diva-e as a Sales Manager, helping coordinate complex projects and supporting companies in successfully implementing digital solutions. His goal is to turn challenges into opportunities and make digital transformation both meaningful and valuable for clients.

See all articles